{"id":"NCT00511914","sponsor":"Novartis Vaccines","briefTitle":"Safety and Immunogenicity of Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture Using the Strain Composition 2007/2008","officialTitle":"A Phase III, Multicenter, Uncontrolled, Open-label Study to Evaluate Safety and Immunogenicity of a Single Intramuscular Dose of a Trivalent Subunit Influenza Vaccine Produced in Mammalian Cell Culture, Using the Strain Composition 2007/2008, When Administered to Adult and Elderly Subjects","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-07","primaryCompletion":"2007-08","completion":"2007-08","firstPosted":"2007-08-06","resultsPosted":"2013-01-17","lastUpdate":"2013-01-24"},"enrollment":135,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Seasonal Influenza Vaccine"],"interventions":[{"type":"BIOLOGICAL","name":"cTIV","otherNames":[]}],"arms":[{"label":"cTIV (Adults)","type":"EXPERIMENTAL"},{"label":"cTIV (Elderly)","type":"EXPERIMENTAL"}],"summary":"Annual trial for registration of sub-unit influenza vaccine produced in mammalian cell culture, using the strain composition 2007/2008, when administered to adult and elderly subjects","primaryOutcome":{"measure":"Geometric Mean Titers (GMT) After 1 Dose of Cell Culture Derived Vaccine (cTIV).","timeFrame":"3 weeks postvaccination (Day 22)","effectByArm":[{"arm":"cTIV (Adults)","deltaMin":22,"sd":null},{"arm":"cTIV (Elderly)","deltaMin":23,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":2,"countries":["Germany"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":68},"commonTop":["Injection site pain","Headache","Fatigue","Injection site induration","Malaise"]}}